Literature DB >> 23845705

Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.

M A Allard1, R Adam, A Ruiz, E Vibert, B Paule, F Levi, M Sebagh, C Guettier, D Azoulay, D Castaing.   

Abstract

AIMS: The discovery of unexpected peritoneal carcinomatosis (PC) at the time of hepatectomy for colorectal liver metastases (CLM) is usually considered a contraindication for continuing resection. The first aim of this study was to assess the long-term outcome of patients operated for CLM, and who presented unexpected PC during laparotomy. The second aim was to identify preoperative predictors of PC.
METHODS: All patients at a single center between 1985 and 2010 who had unexpected PC, discovered during planed resection of CLM, and negative preoperative imaging for PC were selected. Clinicopathological data were retrospectively analyzed to assess survival outcomes and to identify predictors of unexpected PC.
RESULTS: Out of the 1340 operated patients for CLM, 42 (3%) had unexpected PC. Only patients (n = 30; 71%) who had PC limited to two abdominal regions (Median peritoneal cancer index (PCI): 2 (1-6)) were resected. Twelve patients were not resected due to the extent of peritoneal disease. The overall survival of the 30 patients resected for CLM who had limited PC was 18% at 5 years (median: 42 months). On multivariate analysis, a previous history of PC, a pT4 stage and bilobar CLM were independent predictors of unexpected PC.
CONCLUSION: Unexpected PC should not be a contraindication for resection provided that the PCI is low and complete resection of all peritoneal and hepatic lesions can be achieved. Previous history of PC, a pT4 primary tumor and bilobar CLM are associated with increased risk of unexpected PC.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CLM; CS; Colorectal liver metastases; FDG; HIPEC; PC; PCI; PET; Unexpected peritoneal carcinomatosis; colorectal liver metastases; cytoreductive surgery; fluorodeoxyglucose; hyperthermic intraperitoneal chemotherapy; peritoneal cancer index; peritoneal carcinomatosis; positron emission tomography

Mesh:

Year:  2013        PMID: 23845705     DOI: 10.1016/j.ejso.2013.06.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

Review 1.  [Assessment of resectability of colorectal liver metastases and extended resection].

Authors:  U Settmacher; H Scheuerlein; F Rauchfuss
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

Review 2.  Oligometastatic Disease in Colorectal Cancer - How to Proceed?

Authors:  Felix Aigner; Johann Pratschke; Moritz Schmelzle
Journal:  Visc Med       Date:  2017-02-03

3.  Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Reese W Randle; Andrea N Doud; Edward A Levine; Clancy J Clark; Katrina R Swett; Perry Shen; John H Stewart; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2014-08-14       Impact factor: 5.344

Review 4.  Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes.

Authors:  William J Hadden; Philip R de Reuver; Kai Brown; Anubhav Mittal; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2016-02-01       Impact factor: 3.647

Review 5.  Therapeutic options for peritoneal metastasis arising from colorectal cancer.

Authors:  Gabriel Glockzin; Hans J Schlitt; Pompiliu Piso
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

6.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.

Authors:  Joshua Lansom; Nayef Alzahrani; Winston Liauw; David L Morris
Journal:  Indian J Surg Oncol       Date:  2015-10-24

Review 7.  The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Tumors and Colorectal Adenocarcinomas.

Authors:  Michael Kuncewitch; Edward A Levine; Perry Shen; Konstantinos I Votanopoulos
Journal:  Clin Colon Rectal Surg       Date:  2018-09-04

8.  Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.

Authors:  Mohammad Adileh; Eyal Mor; Arie Ariche; Aviram Nissan; Dan Assaf; Haggai Benvenisti; Shachar Laks; Almog Ben-Yaacov; Gal Schtrechman; David Hazzan; Einat Shacham-Shmueli; Ofer Margalit; Naama Halpern; Dan Aderka; Daria Perelson
Journal:  Ann Surg Oncol       Date:  2020-09-23       Impact factor: 5.344

9.  BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES.

Authors:  Orlando Jorge Martins Torres; Márcio Carmona Marques; Fabio Nasser Santos; Igor Correia de Farias; Anelisa Kruschewsky Coutinho; Cássio Virgílio Cavalcante de Oliveira; Antonio Nocchi Kalil; Celso Abdon Lopes de Mello; Jaime Arthur Pirola Kruger; Gustavo Dos Santos Fernandes; Claudemiro Quireze; André M Murad; Milton José de Barros E Silva; Charles Edouard Zurstrassen; Helano Carioca Freitas; Marcelo Rocha Cruz; Rui Weschenfelder; Marcelo Moura Linhares; Leonaldson Dos Santos Castro; Charles Vollmer; Elijah Dixon; Héber Salvador de Castro Ribeiro; Felipe José Fernandez Coimbra
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.